|
| valid until |
Stand 23.04.2024 | | | May | Apr | Mar | Feb | Jan | Dec | Nov | Oct | Sep | Aug | Jul | Jun |
---|
Group | Material | RVNR | 2025 | 2025 | 2025 | 2025 | 2025 | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 | 2024 |
---|
Haemostasis I (TPZ,INR,aPTT) | Plasma | 221 | | | | | | | | | | | | |
Haemostasis II (Fib,TT) | Plasma | 222 | | | | | | | | | 1621 | | | |
Haemostasis III (FII, FV, FVII, FX) | Plasma | 223 | | | | | | | | | 1616 | | | |
Haemostasis V (AT, Prot-C, Prot-S) | Plasma | 225 | | | | | | | | | 1615 | | | |
Haemostasis VI (D-Dimer) | Plasma | 226 | | | | | | | | | 1622 | | | |
Haemostasis VII ( Faktor VIII chromogen) | Citrat-Plasma | 227 | | | | | | | | | 1618 | | | |
Haemostasis VII (vWF-AG, vWF-RiCof, FVIII) | Plasma | 227 | | | | | | | | | | | | |
Haemostasis XX (APC) | Plasma | 288 | | | | | | | | | | | | |
Haemostasis XXV (Apixaban) | Plasma | 504 | | | | | | | | 1655 | | | | |
Haemostasis XXXIII (Emicizumab) | Plasma | 506 | | | | | | | | 1645 | 1620 | | | |
Haemostasis-ECAT (APC/antiXa/FVIII-Inh/FIX-Inh/PAI-1) | Plasma | TH | | | | | | | | | | | | |
Haemostasis-ECAT (Lupus) | Plasma | TH | | | | | | | | | | | | |
Haemostasis-ECAT (Thrombin Generation Test) | Plasma | TG | | | | | | | | | | | | |
Haemostatsis IV (Factor IX,XI,XII,XIII) | Plasma | 224 | | | | | | | | | 1617 | | | |
Hematology Auto Differentials (CAP) | EDTA | FH9 | | | | | | | | | 0410. | | | |
Hemoglobin A1c (CAP) | EDTA | GH2 | | | | | | 0420 | | | | | | |
Hormone 1(RFB) | Serum | HM | | | | | | | | | | | | |
Hormones (RFB) | Serum | HP | | | | | | | | | | | 0343 | |
Hormones-Fertility | Serum | 297 | | | | | | | | | 1604-1 | | | |
|